GeneDx Holdings Corp.WGSNASDAQ

Revenue (LTM)

$428M

+40.0% YoY

Net Income (LTM)

$-21M

+59.8% YoY

Free Cash Flow

$14M

Revenue CAGR (5Y)

+19.1%

Marginsimproving

FCFTurned positive

Unprofitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	212	235↑10.6%	203↓13.7%	305↑50.8%	428↑40.0%
Gross Profit	-17	-27↓61.1%	90↑436.5%	194↑116.0%	298↑53.4%
Operating Income	-446	-668↓49.6%	-181↑73.0%	-23↑87.1%	-12↑49.2%
Net Income	-245	-549↓123.7%	-176↑68.0%	-52↑70.3%	-21↑59.8%
EBITDA	-221	-398↓80.4%	-136↑65.7%	-1↑99.1%	7↑625.9%
EPS Diluted	-74.93	-53.63↑28.4%	-7.23↑86.5%	-1.94↑73.2%	-0.73↑62.4%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	401	137↓65.7%	100↓27.5%	85↓14.5%	105↑23.2%
Total Current Assets	484	213↓56.0%	182↓14.2%	198↑8.6%	268↑35.5%
Total Assets	554	545↓1.6%	419↓23.2%	419↑0.1%	570↑36.0%
Total Current Liabilities	101	144↑42.5%	59↓59.2%	55↓6.8%	109↑98.7%
Total Liabilities	166	292↑75.6%	191↓34.6%	174↓8.7%	262↑50.5%
Total Equity	388	254↓34.6%	228↓10.1%	245↑7.6%	308↑25.7%
Total Debt	33	77↑134.8%	120↑55.3%	116↓3.0%	152↑30.8%
Net Debt	-368	-60↑83.6%	20↑133.3%	31↑54.1%	47↑51.7%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	-190	-319↓67.6%	-180↑43.6%	-28↑84.2%	33↑216.8%
Capital Expenditure	-21	-14↑31.1%	-6↑60.1%	-5↑3.9%	-19↓246.3%
Free Cash Flow	-211	-333↓57.9%	-186↑44.3%	-34↑81.7%	14↑142.0%
Stock-Based Comp	219	42↓80.9%	-0↓100.8%	9↑2903.1%	32↑252.0%
Net Change in Cash	283	-263↓193.2%	-38↑85.7%	-14↑61.7%	20↑236.8%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance